Category Archives: FDA

The serious adverse events caused by antipsychotics

Posted on January 13, 2018 by admin

February 1, 2014

Posted in - Pharma, FDA | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

Posted on January 4, 2018 by admin

May 15, 2016- by Steven E. Greer, MD The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil)

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment

CDER Director Janet Woodcock on new drug safety strategies

Posted on January 2, 2018 by admin

November 16, 2010- by Steven E. Greer, MD We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible

Posted in - Pharma, FDA | Leave a comment

The 23andMe home genetics test kit controversy

Posted on November 26, 2017 by admin

December 19, 2013- Interviewed by Steven E. Greer,  MD

Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry | Leave a comment

Google wants your DNA now (Not just with 23andMe)

Posted on November 26, 2017 by admin

Opinion December 17, 2013- By Steven E. Greer, MD The Wall Street Journal published an article explaining how the pharmaceutical industry data mines

Posted in - Opinion, - Policy, FDA, Genetics | Leave a comment

Interview with the CEO of Neovasc, Alexei Marko

Posted on November 17, 2017 by admin
Posted in - Medical Devices, Cardiology, FDA | Leave a comment

Early stoppage of clinical trials

Posted on October 31, 2017 by admin

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

CBS News Promotes More Pro-Coffee Junk Science

Posted on July 11, 2017 by admin

July 11, 2017- by Steven E. Greer, MD How does one become a successful TV medical doctor pundit? First, you have to leave your medical ethics

Posted in - Opinion, Cardiology, CDC, Congress, Cornell, FDA, Primary care medicine, Psychology Psychiatry | Leave a comment

The Biggest Healthcare Stories of 2016

Posted on December 26, 2016 by admin

December 26, 2016- by Steven E. Greer, MD for The Healthcare Channel Policy changes dominated the 2016 year in healthcare news. There were few important new drug

Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - The Weekly Summary, CMS, FDA | Leave a comment

Robert De Niro gives credibility to vaccine truthers

Posted on October 14, 2016 by admin

Update March 27, 2016- Less than 24-hours after our story, this film has been pulled from the lineup. It was our story that got the heads of

Posted in - Pharma, - Reviews, books, devices, CDC, FDA, NIH, Pediatrics, Primary care medicine | Leave a comment

Man who oversaw one of the biggest academic research frauds in medical history is poised to become the next FDA Commissioner

Posted on February 7, 2016 by admin

Update February 7, 2016- Key senators, including Bernie Sanders, are now threatening to filibuster

Posted in - Opinion, - Policy, Cardiology, FDA, NIH | Leave a comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

Posted on December 7, 2015 by admin

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

Martin Shkreli, CEO of Turing Pharmaceuticals, could be the Bernie Madoff of the drug industry

Posted on September 25, 2015 by admin

September 22, 2015- by Steven E. Greer, MD Making national news today was Martin Shkreli, the baby-faced, greasy-haired, disheveled-looking

Posted in - Biotech, - Pharma, Congress, FDA | Leave a comment

Stephen Colbert mocks the new “female viagra” flibanserin

Posted on September 24, 2015 by admin

September 20, 2015- Well, the real CBS news did an atrocious job covering this story, so the fake newsman

Posted in - Opinion, FDA, Obstetrics and Gynecology, Psychology Psychiatry, Urology | Leave a comment

Actavis 1000% drug price hike: a case for healthcare reform

Posted on September 22, 2015 by admin

Update September 21, 2015- The Healthcare Channel was the first to report in 2009 on the business strategy of acquiring cheap generic drugs, cornering the market, then raising

Posted in - Biotech, - Generics, - Opinion, - Policy, CMS, Congress, FDA, Infectious disease | Leave a comment

The newly approved Edwards Lifesciences Sapien 3 aortic valve

Posted on July 5, 2015 by admin

July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA | Leave a comment

The deadly risks of TAVR being downplayed to patients by hospitals

Posted on January 18, 2015 by admin

January 18, 2015- By Steven E. Greer, MD On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to

Posted in - Medical Devices, - Opinion, Cardiac surgery, Cardiology, FDA | Leave a comment

Occluding the left atrial appendage to prevent stroke in A-fib

Posted on May 17, 2014 by admin

May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

The FDA’s new Breakthrough status for new drug applications

Posted on May 8, 2014 by admin

May 24, 2013- Interviewed by Steven E. Greer, MD Janet Woodcock, MD,

Posted in - Pharma, FDA | Leave a comment

FDA official, William Maisel, pleads guilty to crime, keeps job

Posted on April 24, 2014 by admin

April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal

Posted in FDA | Leave a comment